New Jersey Cannabis Regulatory Commission recently amended their marijuana testing standards in order to require more comprehensive tests from licensed cannabis businesses.
ROI-NJ recently unveiled new guidelines that include reduced testing sample sizes and more specific results for different product categories as well as expanded cannabinoid testing capabilities, according to their announcement at an industry meeting.
The commission reduced acceptable testing batch sizes from 100 pounds to just over 33 pounds and assigned maximum lot sizes based on product categories such as “concentrates, vaporized formulations, ingestible products transmucosal cannabis-infused products and dermal cannabis-infused products”, reported ROI-NJ. Cannabis testing labs have until March 19 to implement these batch size modifications.
CRC also adopted testing rules to address contaminants like foreign matter, pesticides, microbes, mycotoxins and heavy metals and must implement consistent testing methodologies across laboratories. Labs have until May 23 to implement protocol changes.
In addition to testing THC and CBD levels, the CRC decided that testing must also encompass levels of THCA, CBDA, CBGGA and CBN.
Christopher Riggs, CRC Acting Executive Director stated, that these new guidelines were created through extensive research conducted jointly with industry experts and regulatory bodies, with consumer protection as their goal in mind.
New Jersey Adopts New Cannabis Testing Standards MEDCAN24
